EcoDrugPlus

Aph1b Gamma Secretase Subunit

Ensembl ID : ENSLCRG00005003009
Gene Symbol: APH1B
3 Cross references
176 Possible Orthologues:

Atp Binding Cassette Subfamily C Member 1

Ensembl ID : ENSLCRG00005016478
Gene Symbol: ABCC1
3 Cross references
201 Possible Orthologues:

Atp-Binding Cassette, Sub-Family C (Cftr/mrp), Member 8

Ensembl ID : ENSLCRG00005015744
Gene Symbol: ABCC8
3 Cross references
225 Possible Orthologues:

Atp-Binding Cassette, Sub-Family C (Cftr/mrp), Member 9

Ensembl ID : ENSLCRG00005014707
Gene Symbol: ABCC9
3 Cross references
231 Possible Orthologues:

Atpase H+/k+ Transporting Subunit Alpha

Ensembl ID : ENSLCRG00005006456
Gene Symbol: ATP4A
3 Cross references
183 Possible Orthologues:

Atpase H+/k+ Transporting Subunit Beta

Ensembl ID : ENSLCRG00005022946
Gene Symbol: ATP4B
3 Cross references
184 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Alpha 2a

Ensembl ID : ENSLCRG00005002072
Gene Symbol: ATP1A2A
3 Cross references
205 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 1

Ensembl ID : ENSLCRG00005009340
Gene Symbol: ATP1B1
3 Cross references
225 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 1b

Ensembl ID : ENSLCRG00005014513
Gene Symbol: ATP1B1B
3 Cross references
219 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 2a

Ensembl ID : ENSLCRG00005003433
Gene Symbol: ATP1B2A
3 Cross references
200 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 2b

Ensembl ID : ENSLCRG00005003223
Gene Symbol: ATP1B2B
3 Cross references
203 Possible Orthologues:

Atr Serine/threonine Kinase

Ensembl ID : ENSLCRG00005014460
Gene Symbol: ATR
3 Cross references
205 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).